Bad news sometimes coincides with good news, with good news winning the day. The bad news came courtesy of the CDC which reported that over 80% of pregnancy-related deaths in the US were preventable. Their data also shows that over 250,000 women experience difficulties during their pregnancies every year. Unfortunately, trends in severe maternal morbidity have worsened over the past decades and hypertension is a leading contributor.
The good news is that sensors and analytical systems are now available that can inexpensively profile, monitor, and assist physicians in helping their patients control and manage their blood pressure. For example, Biobeat's ABPM (Ambulatory Blood Pressure Monitoring) solution was engineered around the company’s small, cuffless blood pressure sensor, artificial intelligence, and robust analysis. The sensor is comfortably attached to the patient's upper chest to measure and log blood pressure and other vitals every fifteen minutes over twenty-four hours. The blood pressure profiles, which I will detail in my next posts, arm physicians with unprecedented actionable insights into their patient's blood pressure, mean arterial pressure, systemic vascular resistance, and cardiac output.
These insights combined with effective intervention can protect the health of expecting mothers and their babies. Please reach out for more information on how cutting-edge sensors and analytics are revolutionizing the diagnosis, treatment, and management of hypertension and its impacts on pregnancy.